Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Hepalink to Acquire Cytovance Biologics

By Pharmaceutical Processing | August 24, 2015

A definitive agreement has been announced by which Hepalink USA, Inc. will acquire Cytovance Biologics, Inc., a leading biopharmaceutical contract development manufacturing company. The addition of Cytovance Biologics to Hepalink USA Inc. and its parent company Shenzhen Hepalink Pharmaceutical Co., Ltd., adds a leading biologics CDMO to its current U.S. portfolio, which also includes Wisconsin-based Scientific Protein Laboratories LLC.

Hepalink’s investment will accelerate Cytovance’s expansion plans which include the addition of 5,000-liter and 10,000-liter mammalian reactors and 1,000-liter and 5,000-liter microbial fermentors, as well as increased analytical capabilities, process development and process characterization capabilities.

Under terms of the stock purchase agreement, Hepalink will acquire Cytovance for $205.68 million in cash, plus certain contingent payments. Upon consummation of the acquisition, Hepalink will hold 100 percent of the equity interest indirectly through Hepalink USA.

The transaction is expected to close in October following regulatory approval. When the transaction is completed, Cytovance management will remain in place, as will its 178 employees in the United States.

Related Articles Read More >

Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE